David M. Knott’s Indaptus Therapeutics INDP Stock Holding History

David M. Knott’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-116	Closed	-$1.13M	–	124
2019 Q2	$1.13M	Sell	116 -14	-11%	-$177K	0.48%	36
2019 Q1	$2.13M	Buy	130 +3	+2%	+$52.6K	0.85%	26
2018 Q4	$2.14M	Hold	127	–	–	1%	21
2018 Q3	$1.6M	Buy	+127	New	+$1.21M	0.52%	33
2018 Q1	–	Sell	-16	Closed	-$180K	–	113
2017 Q4	$180K	Buy	+16	New	+$248K	0.07%	79

Other funds holding INDP

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

David M. Knott's INDP Position: Q3 2019 in Review

David M. Knott sold out of Indaptus Therapeutics (INDP) in Q3 2019, closing a stake of 116 shares — an estimated $1.13M sold.

David M. Knott first reported a position in INDP in Q4 2017 and held it in 5 quarters. The position peaked at $2.14M in Q4 2018. 33 funds tracked by Wall St. Rank hold INDP as of Q3 2019.

David M. Knott reported no remaining Indaptus Therapeutics position as of Q3 2019 after selling out during the quarter.
David M. Knott sold 116 Indaptus Therapeutics shares in Q3 2019, an estimated $1.13M.
David M. Knott first reported a position in Indaptus Therapeutics in Q4 2017 and held it in 5 quarters.
David M. Knott's Indaptus Therapeutics position peaked at $2.14M in Q4 2018.
33 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2019.

Based on David M. Knott's 13F filing for Q3 2019, filed 12 Nov 2019.